Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.49 USD
Change Today 0.00 / 0.00%
Volume 0.0
IFIT On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

isatori inc (IFIT) Key Developments

iSatori, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

iSatori, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company has posted total revenue of $2,488,892 against $2,918,367 a year ago. Loss from operations was $490,176 against income from operations of $213,951 a year ago. Loss before income tax was $514,916 against income before income tax of $399,481 a year ago. Net loss was $522,712 or $0.04 diluted per share against net income of $336,099 or $0.02 diluted per share a year ago. The reduction in revenues is primarily a result of the unanticipated decline in revenues of a product mix shift from the sales of the weight loss dietary supplement segment in iSatori's business, beginning in the third quarter 2014, which was partially offset by sales of new products and product lines in the sports nutrition segments of its business. For the six months, the company has posted $5,917,716 against $6,179,634 a year ago. Loss from operations was $364,058 against income from operations of $568,212 a year ago. Loss before income tax was $485,597 against income before income tax of $751,542 a year ago. Net loss was $496,323 or $0.04 diluted per share against net income of $672,337 or $0.05 diluted per share a year ago.

iSatori, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2015

iSatori, Inc. reported unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenue of $3,428,823 against $3,219,244 for the same period a year ago. The increase in revenues can be attributed to increasing demand for their category-creating Bio-Gro product and newly released products which were not available during the three-month period ended March 31, 2014, such as Pre-Gro and Hyper-Gro (both of which are fortified with Bio-Gro). Adjustments from revenues (for retailer advertising discounts, returns, promotional credits, and coupons) increased $24,000 or 5% to $535,000 for the three months ended March 31, 2015, compared to $511,000 for the same period in the previous year period. Income from operations was $126,118 against $354,263 for the same period a year ago. Income before income taxes was $29,319 against $352,061 for the same period a year ago. Total operating expenses decreased by $70,000 or 4% for first three months ended March 31, 2015, to $1,593,000 from $1,663,000 for the same period prior year. As a result, net income was $26,389 against $336,238 for the same period a year ago.

iSatori, Inc. Provides Earnings Guidance for the First Quarter Ended March 31, 2015

iSatori, Inc. provided earnings guidance for the first quarter ended March 31, 2015. For the quarter, the company's total revenue, after discounts, trade promotions, and retail allowances, is estimated to be approximately $3.4 million compared to $3.2 million a year ago. A positive net income is estimated to be reported.

iSatori, Inc. to Report Q1, 2015 Results on May 14, 2015

iSatori, Inc. announced that they will report Q1, 2015 results on May 14, 2015

iSatori, Inc. Announces the Removal of the Weight-Loss Supplement MX-LS7(TM) v2 from the Supplement Market

iSatori, Inc. announced the removal of the weight-loss supplement MX-LS7(TM) v2 from the supplement market, accelerating the previously planned deletion of the item. Although an ingredient in question, Acacia rigidula, only makes up a small percentage of the total MX-LS7(TM)v2 formula and appears to be DSHEA compliant, out of precaution, iSatori is ceasing its distribution and sales of MX-LS7(TM)v2.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IFIT:US $0.49 USD 0.00

IFIT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $43.07 USD -1.07
USANA Health Sciences Inc $137.93 USD -0.42
Vitamin Shoppe Inc $34.60 USD -0.30
View Industry Companies
 

Industry Analysis

IFIT

Industry Average

Valuation IFIT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 4.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISATORI INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.